These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of size and sequence on the iontophoretic delivery of oligonucleotides. Brand RM; Wahl A; Iversen PL J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967 [TBL] [Abstract][Full Text] [Related]
4. Iontophoresis of bases, nucleosides, and nucleotides. van der Geest R; Hueber F; Szoka FC; Guy RH Pharm Res; 1996 Apr; 13(4):553-8. PubMed ID: 8710745 [TBL] [Abstract][Full Text] [Related]
5. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. Al-Khalili M; Meidan VM; Michniak BB AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941 [TBL] [Abstract][Full Text] [Related]
6. Iontophoretic transdermal delivery of haloperidol. Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847 [TBL] [Abstract][Full Text] [Related]
7. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system. Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955 [TBL] [Abstract][Full Text] [Related]
8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM; Corish J; Corrigan OI; Fitzpatrick D Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130 [TBL] [Abstract][Full Text] [Related]
9. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough. Dubey S; Kalia YN J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950 [TBL] [Abstract][Full Text] [Related]
10. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides. Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264 [TBL] [Abstract][Full Text] [Related]
11. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes. Brand RM; Haase K; Hannah TL; Iversen PL J Invest Dermatol; 1998 Dec; 111(6):1166-71. PubMed ID: 9856834 [TBL] [Abstract][Full Text] [Related]
12. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro. Kumar MG; Lin S Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546 [TBL] [Abstract][Full Text] [Related]
13. Optimization of iontophoretic parameters for the transdermal delivery of methotrexate. Vemulapalli V; Banga AK; Friden PM Drug Deliv; 2008 Sep; 15(7):437-42. PubMed ID: 18712621 [TBL] [Abstract][Full Text] [Related]
14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718 [TBL] [Abstract][Full Text] [Related]
15. Irontophoresis: transdermal delivery of iron by iontophoresis. Murthy SN; Vaka SR J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049 [TBL] [Abstract][Full Text] [Related]
16. Parameters controlling topical delivery of oligonucleotides by electroporation. Regnier V; Le Doan T; Préat V J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977 [TBL] [Abstract][Full Text] [Related]
17. Transdermal iontophoretic drug delivery: advances and challenges. Ita K J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291 [TBL] [Abstract][Full Text] [Related]